Skip to content

Application of narrative medicine in diagnosis and care of patients with secondary hyperparathyroidism

Application and effect evaluation of narrative medicine in diagnosis and care of patients with secondary hyperparathyroidism

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043648
Enrollment
Unknown
Registered
2021-02-24
Start date
2021-03-05
Completion date
Unknown
Last updated
2021-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary hyperparathyroidism

Interventions

Intervention group:Receive narrative nursing on the basis of routine nursing and routine health education. Details are as follows: The form of intervention is one-to-one individual intervention
A safe, comfortable and private place, such as the talking room, meeting room or classroom, was selected for face-to-face communication.
control group:Routine perioperative nursing and routine health education were given to patients with SHPT.

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Aged >= 18 years; There were clear imaging and pathological diagnostic basis for SHPT. Clear mind, normal communication ability and willing participant. Exclusion criteria: inability to cooperate with investigators due to consciousness disorder or mental illness; People who do not know their illness; Patients enrolled in a similar study.

Exclusion criteria

Exclusion criteria: Participants whose condition deteriorated and could not continue; Patients voluntarily withdrew from the study for other reasons.

Design outcomes

Primary

MeasureTime frame
Psychological Distress;Depression;Connor-Davidson Resilience;Perceived social support;

Countries

ChIna

Contacts

Public ContactPeng Lili

Department of Interventional Medicine, China-Japan Friendship Hospital,

doctor750197@163.com+86 13146675166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026